Dr. Jeffrey R. Antimarino, MD

Dr. Antimarino practices at UPMC East in Monroeville, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Antimarino's NPI, 1417067760, was assigned on August 30, 2006. Dr. Antimarino graduated from Creighton University School of Medicine - Omaha in 1993. Dr. Antimarino holds Pennsylvania license MD430564.

Dr. Antimarino's primary practice is UPMC East, at 2775 Mosside Boulevard, Monroeville, PA 15146 in Allegheny County. The practice phone is (412) 357-3000.

Dr. Antimarino's primary practice is UPMC East in Monroeville, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Antimarino is also affiliated with Forbes Hospital. The medical group on file is Bellissimo Plastic Surgery & Medi Spa. Dmand AI also links Dr. Antimarino to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Antimarino practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Antimarino's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Antimarino is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Antimarino's licenses on file in 2 states: Pennsylvania and California.

Dmand AI lists cancerous skin growth removal among the conditions Dr. Antimarino treats.

CMS data shows 24 Medicare services from Dr. Antimarino across 1 procedure code in 2024, all of them office visits, for 24 Medicare patients. Medicare paid $1,301 for them. Every service was in an office.

CMS counts 24 Medicare patients who saw Dr. Antimarino in 2024. 63% of them have high cholesterol, and 50% have arthritis. Their average risk score is 0.74, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Antimarino's median patient age at 54, with 75% women.

In 2024, Dr. Antimarino wrote 70 Medicare Part D claims for 33 patients. 99% of them were for generic drugs. CMS names the drug for 50 of them, across 2 drugs with 11 or more claims each, at $194 in total drug cost. In 2023, CMS named 79 claims across 3 drugs.

Dr. Antimarino accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of melanoma (skin cancer) excision by Dr. Antimarino, more than 66% of the clinicians it reports for that procedure.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Antimarino. Dr. Antimarino's most frequent co-author is David Newcomb Herndon, MD.

CMS Open Payments shows 305 general payments to Dr. Antimarino from 18 drug and device companies from 2016 to 2025. Gifts make up the largest share, 40% of the total. Allergan Inc. paid the most, $130,312.

Dmand AI lists 5 awards for Dr. Antimarino, most recently 10 Best Patient Satisfaction in 2016.

Dr. Antimarino graduated from Creighton University School of Medicine - Omaha in 1993. Dr. Antimarino is a member of ACS, American Institute of Plastic Surgeons, AMA, ASAPS, ASPS and Greater Pittsburgh Plastic Surgery Society.

Dr. Antimarino is in network with 15 carriers, including Elevance, Highmark and HCSC. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.